Diabetes Research and Clinical Practice
Volume 62, Issue 3 , Pages 169-175 , December 2003

Leptin receptor polymorphism is associated with serum lipid levels and impairment of cholesterol lowering effect by simvastatin in Japanese men

  • Akiko Takahashi-Yasuno

      Affiliations

    • Laboratory of Diabetes, Obesity and Molecular Medicine, Division of Endocrinology, Diabetes and Metabolism, Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine, 54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan
    • ,
  • Hiroaki Masuzaki

      Affiliations

    • Laboratory of Diabetes, Obesity and Molecular Medicine, Division of Endocrinology, Diabetes and Metabolism, Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine, 54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81-75-751-3172; fax: +81-75-771-9452
    • ,
  • Takashi Miyawaki

      Affiliations

    • Laboratory of Diabetes, Obesity and Molecular Medicine, Division of Endocrinology, Diabetes and Metabolism, Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine, 54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan
    • Health Check-up Center, NTT Kyoto Hospital (West Japan), 1 Nishi Kujyo Nanden-cho, Minami-ku, Kyoto 606-8441, Japan
    • ,
  • Yoshihiro Ogawa

      Affiliations

    • Laboratory of Diabetes, Obesity and Molecular Medicine, Division of Endocrinology, Diabetes and Metabolism, Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine, 54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan
    • ,
  • Naoki Matsuoka

      Affiliations

    • Laboratory of Diabetes, Obesity and Molecular Medicine, Division of Endocrinology, Diabetes and Metabolism, Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine, 54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan
    • ,
  • Tatsuya Hayashi

      Affiliations

    • Laboratory of Diabetes, Obesity and Molecular Medicine, Division of Endocrinology, Diabetes and Metabolism, Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine, 54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan
    • ,
  • Kiminori Hosoda

      Affiliations

    • Laboratory of Diabetes, Obesity and Molecular Medicine, Division of Endocrinology, Diabetes and Metabolism, Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine, 54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan
    • ,
  • Gen Inoue

      Affiliations

    • Laboratory of Diabetes, Obesity and Molecular Medicine, Division of Endocrinology, Diabetes and Metabolism, Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine, 54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan
    • ,
  • Yasunao Yoshimasa

      Affiliations

    • Laboratory of Diabetes, Obesity and Molecular Medicine, Division of Endocrinology, Diabetes and Metabolism, Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine, 54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan
    • ,
  • Kazuwa Nakao

      Affiliations

    • Laboratory of Diabetes, Obesity and Molecular Medicine, Division of Endocrinology, Diabetes and Metabolism, Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine, 54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan

Received 3 April 2003 ,Revised 4 June 2003 ,Accepted 30 June 2003.

References 

  1. Simons LA. Simvastatin in severe primary hypercholesterolemia: efficacy, safety, and tolerability in 595 patients over 18 weeks. The Principal Investigators. Clin. Cardiol. 1993;16:317–322
  2. Chung WK, Belfi K, Chua M, et al.  Heterozygosity for Lep(ob) or Lep(rdb) affects body composition and leptin homeostasis in adult mice. Am. J. Physiol. 1998;274:R985–R990
  3. Campfield LA, Smith FJ, Guisez Y, Devos R, Burn P. Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science. 1995;269:546–549
  4. Jiang XC, Bruce C, Mar J, et al.  Targeted mutation of plasma phospholipid transfer protein gene markedly reduces high-density lipoprotein levels. J. Clin. Invest. 1999;103:907–914
  5. Herberg L, Coleman DL. Laboratory animals exhibiting obesity and diabetes syndromes. Metabolism. 1977;26:59–99
  6. Leibel RL, Chung WK, Chua SC. The molecular genetics of rodent single gene obesities. J. Biol. Chem. 1997;272:31937–31940
  7. Silver DL, Jiang XC, Tall AR. Increased high density lipoprotein (HDL), defective hepatic catabolism of ApoA-I and ApoA-II, and decreased ApoA-I mRNA in ob/ob mice. Possible role of leptin in stimulation of HDL turnover. J. Biol. Chem. 1999;274:4140–4146
  8. Cargill M, Altshuler D, Ireland J, et al.  Characterization of single-nucleotide polymorphisms in coding regions of human genes. Nat. Genet. 1999;22:231–238
  9. Matsuoka N, Ogawa Y, Hosoda K, et al.  Human leptin receptor gene in obese Japanese subjects: evidence against either obesity-causing mutations or association of sequence variants with obesity. Diabetologia. 1997;40:1204–1210
  10. Chagnon YC, Chung WK, Perusse L, Chagnon M, Leibel RL, Bouchard C. Linkages and associations between the leptin receptor (LEPR) gene and human body composition in the Quebec Family Study. Int. J. Obes. Relat. Metab. Disord. 1999;23:278–286
  11. Quinton ND, Lee AJ, Ross RJM, Eastell R, Blakemore AIF. A single nucleotide polymorphism (SNP) in the leptin receptor is associated with BMI, fat mass and leptin levels in postmenopausal Caucasian women. Hum. Genet. 2001;108:233–236
  12. Stefan N, Vozarova B, Parigi AD, et al.  The Gln223Arg polymorphism of the leptin receptor in Pima Indians: influence on energy expenditure, physical activity and lipid metabolism. Int. J. Obes. 2002;26:1629–1632
  13. Hickey MS. Gender differences in serum leptin levels in humans. Biochem. Mol. Med. 1996;59:1–6
  14. Goldstein JL, Brown MS. Familial hypercholesterolemia: identification of a defect in the regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity associated with overproduction of cholesterol. Proc. Natl. Acad. Sci. USA. 1973;70:2804–2808
  15. Goldstein JL, Schrott HG, Hazzard WR, Bierman EL, Motulsky AG. Hyperlipidemia in coronary heart disease. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia. J. Clin. Invest. 1973;52:1544–1568
  16. de Silva AM, Walder KR, Aitman TJ, et al.  Combination of polymorphisms in OB-R and the OB gene associated with insulin resistance in Nauruan males. Int. J. Obes. Relat. Metab. Disord. 1999;23:816–822
  17. Hahn P. Cholesterol metabolism in obese mice. Can. J. Biochem. 1980;58:1258–1260
  18. Goldstein JL, Brown MS. Regulation of the mevalonate pathway. Nature. 1990;343:425–430
  19. Gebhard RL, Levine AS, Prigge WF, Brown DM, Handwerger BS, Morley JE. Hepatic and intestinal 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in genetically diabetic mice. Biochem. Biophys. Res. Commun. 1983;113:638–644
  20. Lin RC. Serum cholesterol, lecithin-cholesterol acyltransferase, and hepatic hydroxymethylglutaryl coenzyme A reductase activities of lean and obese Zucker rats. Metabolism. 1985;34:19–24
  21. Jiao S, Matsuzawa Y, Matsubara YK, et al.  Abnormalities of plasma lipoproteins in a new genetically obese rat with non-insulin-dependent diabetes mellitus (Wistar fatty rat). Int. J. Obes. 1991;15:487–495
  22. Levin N, Nelson C, Gurney A, Vandlen R, Sauvage F. Decreased food intake does not completely account for adiposity reduction after ob protein infusion. Proc. Natl. Acad. Sci. USA. 1996;93:1726–1730
  23. VanPatten S, Ranginani N, Shefer S, Nguyen LB, Rossetti L, Cohen DE. Impaired biliary lipid secretion in obese Zucker rats: leptin promotes hepatic cholesterol clearance. Am. J. Physiol. Gastrointest. Liver Physiol. 2001;281:G393–G404
  24. Minokoshi Y, Kim YB, Peroni OD, et al.  Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature. 2002;415:339–343
  25. Ferrer A, Caelles C, Massot N, Hegardt FG. Activation of rat liver cytosolic 3-hydroxy-3-methylglutaryl coenzyme A reductase kinase by adenosine 5′-monophosphate. Biochem. Biophys. Res. Commun. 1985;132:497–504
  26. Chung WK, Power-Kehoe L, Chua M, Leibel RL. Mapping of the OB receptor (OBR) to 1p in a region of non-conserved gene order from mouse and rat to human. Genome Res. 1996;6:431–438
  27. Winick JD, Stoffel M, Friedman JM. Identification of microsatellite markers linked to the human leptin receptor gene on chromosome 1. Genomics. 1996;36:221–222
  28. Allayee H, Krass KL, Pajukanta P, et al.  Locus for elevated apolipoprotein B levels on chromosome 1p31 in families with familial combined hyperlipidemia. Circ. Res. 2002;90:926–931
  29. Thompson DB, Ravussin E, Bennett PH, Bogardus C. Structure and sequence variation at the human leptin receptor gene in lean and obese Pima Indians. Hum. Mol. Genet. 1997;6:675–679
  30. Kuivenhoven JA, Jukema JW, Zwinderman AH, et al.  The role of a common variant of the cholesteryl ester transfer protein gene in the progression of coronary atherosclerosis. The Regression Growth Evaluation Statin Study Group. New Engl. J. Med. 1998;338:86–93
  31. Tall AR. Plasma high density lipoprotein. Metabolism and relationship to atherogenesis. J. Clin. Invest. 1990;86:379–384
  32. Kondo I, Berg K, Drayna D, Lawn R. DNA polymorphism at the locus for human cholesteryl ester transfer protein (CETP) is associated with high density lipoprotein cholesterol and apolipoprotein levels. Clin. Genet. 1989;35:49–56
  33. Freeman DJ, Griffin BA, Holmes AP, et al.  Regulation of plasma HDL cholesterol and subfraction distribution by genetic and environmental factors: associations between the Taq I B RFLP in the CETP gene and smoking and obesity. Arterioscler. Thromb. 1994;14:336–344
  34. Fumeron F, Betoulle D, Luc G, et al.  Alcohol intake modulates the effect of a polymorphism of cholesteryl ester transfer protein gene on plasma high density lipoprotein and the risk of myocardial infarction. J. Clin. Invest. 1995;96:1664–1671

PII: S0168-8227(03)00163-3

doi: 10.1016/S0168-8227(03)00163-3

Diabetes Research and Clinical Practice
Volume 62, Issue 3 , Pages 169-175 , December 2003

Article Tools

* Image Usage & Resolution